Published 2000 | Version v1.0.0
Journal Article Open
Sumatriptan Nasal Spray for Acute Migraine
A multicenter, randomized, double-blind, placebo-controlled trial of sumatriptan nasal spray (5 mg, 10 mg, and 20 mg) was conducted in 653 adolescents presenting with acute migraine at the Palm Beach Headache Center, Florida; Cleveland Clinic, OH; Michigan Headache Institute, Ann Arbor; and San Antonio Center, TX.
Files (2.8 MB)
||2.8 MB||Preview Download|
2000When the item was originally created.